# Alamar Biosciences, Inc. (ALMR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALMR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 55.46M | $ -34.52M | $ -35.91M | $ 51.41M | $ 312.86M |
| 2025 | N/A | N/A | N/A | $ 41.47M | $ -158.95M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.16 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 11.85 |

## Other views

- [Metrics](https://sponda.capital/en/ALMR.md)
- [Charts](https://sponda.capital/en/ALMR/charts.md)
- [Compare](https://sponda.capital/en/ALMR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.